• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒 RNA 依赖性 RNA 聚合酶的活性和抑制机制。

Mechanisms of activity and inhibition of the hepatitis C virus RNA-dependent RNA polymerase.

机构信息

Department of Microbial Biotechnology, Institute of Biochemistry and Biotechnology, Faculty of Life Sciences, Martin-Luther-University Halle-Wittenberg, D-06120 Halle/Saale, Germany.

出版信息

J Biol Chem. 2010 Apr 30;285(18):13685-93. doi: 10.1074/jbc.M109.082206. Epub 2010 Mar 1.

DOI:10.1074/jbc.M109.082206
PMID:20194503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2859531/
Abstract

The RNA-dependent RNA polymerase NS5B is a key enzyme of the replication of hepatitis C virus (HCV) and a major therapeutic target. Applying a novel continuous assay with highly purified protein and a fluorescent RNA-template we provide for the first time a comprehensive mechanistic description of the enzymatic reaction. Using fluorescence spectroscopy, the kinetics of NS5B was confirmed to consist of two half-reactions, namely substrate binding and turnover. Determining the binding constants of the substrates and the rate constants of individual reaction steps, NS5B was shown to bind the template single-stranded RNA with high affinity (nanomolar range) and in a stepwise process that reflects the substrate positioning. As demonstrated by CD, NTP(s) binding caused a tertiary structural change of the enzyme into an active conformation. The second half-reaction was dissected into a sequential polymerization and a subsequent, rate-limiting product release reaction. Taking advantage of these tools, we analyzed the mechanism of action of the NS5B inhibitor HCV-796, which was shown to interfere with the formation of double-stranded RNA by blocking the second half-reaction.

摘要

RNA 依赖性 RNA 聚合酶 NS5B 是丙型肝炎病毒 (HCV) 复制的关键酶,也是主要的治疗靶点。本研究应用新型连续分析方法,使用高度纯化的蛋白和荧光 RNA 模板,首次全面描述了酶反应的机制。通过荧光光谱法,证实 NS5B 的动力学由两个半反应组成,即底物结合和周转率。确定底物的结合常数和各个反应步骤的速率常数后,表明 NS5B 以高亲和力(纳摩尔范围)结合单链 RNA 模板,并以反映底物定位的逐步过程进行。如 CD 所示,NTP(s) 结合导致酶的三级结构发生变化,形成活性构象。第二个半反应被剖析为顺序聚合和随后的限速产物释放反应。利用这些工具,我们分析了 NS5B 抑制剂 HCV-796 的作用机制,该抑制剂通过阻断第二个半反应来干扰双链 RNA 的形成。

相似文献

1
Mechanisms of activity and inhibition of the hepatitis C virus RNA-dependent RNA polymerase.丙型肝炎病毒 RNA 依赖性 RNA 聚合酶的活性和抑制机制。
J Biol Chem. 2010 Apr 30;285(18):13685-93. doi: 10.1074/jbc.M109.082206. Epub 2010 Mar 1.
2
Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.使用对模板/引物底物亲和力较低的NS5B鉴定出的丙型肝炎病毒聚合酶特异性抑制剂。
Nucleic Acids Res. 2004 Jan 22;32(2):422-31. doi: 10.1093/nar/gkh160. Print 2004.
3
Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.抑制丙型肝炎病毒RNA依赖性RNA聚合酶的手指亚结构域特异性单克隆抗体的功能特性
J Biol Chem. 2008 Aug 29;283(35):24089-102. doi: 10.1074/jbc.M803422200. Epub 2008 Jun 23.
4
Ligand-induced changes in hepatitis C virus NS5B polymerase structure.配体诱导的丙型肝炎病毒 NS5B 聚合酶结构变化。
Antiviral Res. 2010 Nov;88(2):197-206. doi: 10.1016/j.antiviral.2010.08.014. Epub 2010 Sep 9.
5
A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.一种基于细胞的 HCV 聚合酶 RNA 合成测定法揭示了聚合酶抑制剂作用机制和 NS5A 调节的新见解。
PLoS One. 2011;6(7):e22575. doi: 10.1371/journal.pone.0022575. Epub 2011 Jul 22.
6
Initiation of RNA synthesis by the hepatitis C virus RNA-dependent RNA polymerase is affected by the structure of the RNA template.丙型肝炎病毒RNA依赖性RNA聚合酶引发的RNA合成受RNA模板结构的影响。
Biochemistry. 2014 Nov 11;53(44):7002-12. doi: 10.1021/bi5006656. Epub 2014 Oct 31.
7
NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.核磁共振揭示了NS5A蛋白的内在无序结构域2作为丙型肝炎病毒RNA聚合酶NS5B的变构调节剂。
J Biol Chem. 2017 Nov 3;292(44):18024-18043. doi: 10.1074/jbc.M117.813766. Epub 2017 Sep 14.
8
Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.针对NS5B聚合酶的可穿透细胞的人源单克隆单链抗体片段对丙型肝炎病毒复制的干扰作用
MAbs. 2014;6(5):1327-39. doi: 10.4161/mabs.29978.
9
1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.1,5-苯二氮䓬类,一类新型丙型肝炎病毒聚合酶非核苷抑制剂。
Antimicrob Agents Chemother. 2008 Dec;52(12):4420-31. doi: 10.1128/AAC.00669-08. Epub 2008 Oct 13.
10
Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus.丙型肝炎病毒非核苷类聚合酶抑制剂的慢结合抑制作用及耐药机制
J Biol Chem. 2009 Jun 5;284(23):15517-29. doi: 10.1074/jbc.M808889200. Epub 2009 Feb 26.

引用本文的文献

1
RNA and Protein Determinants Mediate Differential Binding of miRNAs by a Viral Suppressor of RNA Silencing Thus Modulating Antiviral Immune Responses in Plants.RNA 和蛋白质决定簇介导病毒 RNA 沉默抑制剂对 microRNAs 的差异性结合,从而调节植物的抗病毒免疫反应。
Int J Mol Sci. 2022 Apr 29;23(9):4977. doi: 10.3390/ijms23094977.
2
Ribosome Pausing at Inefficient Codons at the End of the Replicase Coding Region Is Important for Hepatitis C Virus Genome Replication.核糖体在复制酶编码区末端非有效密码子处暂停对丙型肝炎病毒基因组复制很重要。
Int J Mol Sci. 2020 Sep 22;21(18):6955. doi: 10.3390/ijms21186955.
3
NF90-NF45 is a selective RNA chaperone that rearranges viral and cellular riboswitches: biochemical analysis of a virus host factor activity.NF90-NF45是一种选择性RNA伴侣蛋白,可重排病毒和细胞核糖开关:病毒宿主因子活性的生化分析
Nucleic Acids Res. 2017 Dec 1;45(21):12441-12454. doi: 10.1093/nar/gkx931.
4
Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase.丙型肝炎病毒(HCV)聚合酶变构抑制剂的生物物理作用模式及选择性分析
Viruses. 2017 Jun 16;9(6):151. doi: 10.3390/v9060151.
5
C-Terminal Auto-Regulatory Motif of Hepatitis C Virus NS5B Interacts with Human VAPB-MSP to Form a Dynamic Replication Complex.丙型肝炎病毒NS5B的C末端自调控基序与人类VAPB-MSP相互作用形成动态复制复合体。
PLoS One. 2016 Jan 19;11(1):e0147278. doi: 10.1371/journal.pone.0147278. eCollection 2016.
6
Initiation of RNA synthesis by the hepatitis C virus RNA-dependent RNA polymerase is affected by the structure of the RNA template.丙型肝炎病毒RNA依赖性RNA聚合酶引发的RNA合成受RNA模板结构的影响。
Biochemistry. 2014 Nov 11;53(44):7002-12. doi: 10.1021/bi5006656. Epub 2014 Oct 31.
7
AUF1 p45 promotes West Nile virus replication by an RNA chaperone activity that supports cyclization of the viral genome.AUF1 p45 通过一种 RNA 伴侣活性促进西尼罗河病毒复制,该活性支持病毒基因组的环化。
J Virol. 2014 Oct;88(19):11586-99. doi: 10.1128/JVI.01283-14. Epub 2014 Jul 30.
8
Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitors.HCV NS5B 聚合酶的结构和调节元件 - β-环和 C 末端尾巴 - 是变构拇指位点 II 抑制剂活性所必需的。
PLoS One. 2014 Jan 9;9(1):e84808. doi: 10.1371/journal.pone.0084808. eCollection 2014.
9
Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective.丙型肝炎病毒对新型特异性靶向抗病毒治疗的耐药性:公共卫生视角
World J Virol. 2013 Feb 12;2(1):6-15. doi: 10.5501/wjv.v2.i1.6.
10
The DEAD-box helicase DDX3 supports the assembly of functional 80S ribosomes.DEAD-box 解旋酶 DDX3 支持功能性 80S 核糖体的组装。
Nucleic Acids Res. 2012 Jun;40(11):4998-5011. doi: 10.1093/nar/gks070. Epub 2012 Feb 9.

本文引用的文献

1
Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus.丙型肝炎病毒非核苷类聚合酶抑制剂的慢结合抑制作用及耐药机制
J Biol Chem. 2009 Jun 5;284(23):15517-29. doi: 10.1074/jbc.M808889200. Epub 2009 Feb 26.
2
HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.HCV796:一种选择性非结构蛋白5B聚合酶抑制剂,在体外、具有嵌合人肝脏的小鼠以及丙型肝炎病毒感染的人类中具有强大的抗丙型肝炎病毒活性。
Hepatology. 2009 Mar;49(3):745-52. doi: 10.1002/hep.22717.
3
Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.对苯并呋喃抑制剂HCV-796敏感性降低的丙型肝炎病毒复制子变体的分子机制
Antimicrob Agents Chemother. 2008 Sep;52(9):3327-38. doi: 10.1128/AAC.00238-08. Epub 2008 Jun 16.
4
Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients.未经治疗的患者中存在对非核苷类而非核苷类聚合酶抑制剂天然耐药的丙型肝炎病毒NS5B变异体。
J Antimicrob Chemother. 2008 Jun;61(6):1205-16. doi: 10.1093/jac/dkn085. Epub 2008 Mar 13.
5
The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to nonnucleoside polymerase or protease inhibitors.丙型肝炎病毒复制子对核苷类似物的耐药性屏障高于对非核苷聚合酶或蛋白酶抑制剂的耐药性屏障。
Antimicrob Agents Chemother. 2008 May;52(5):1604-12. doi: 10.1128/AAC.01317-07. Epub 2008 Feb 19.
6
Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.针对丙型肝炎病毒NS3-4A丝氨酸蛋白酶或NS5B RNA依赖性RNA聚合酶的新型治疗药物研发进展。
Adv Drug Deliv Rev. 2007 Oct 10;59(12):1242-62. doi: 10.1016/j.addr.2007.04.016. Epub 2007 Aug 11.
7
Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections.丙型肝炎病毒NS5B聚合酶的非核苷抑制剂:治疗丙型肝炎病毒感染新型药物的发现与开发进展
Curr Opin Investig Drugs. 2007 Aug;8(8):614-34.
8
High resolution footprinting of the hepatitis C virus polymerase NS5B in complex with RNA.丙型肝炎病毒聚合酶NS5B与RNA复合物的高分辨率足迹分析。
J Biol Chem. 2007 Jun 8;282(23):16907-16. doi: 10.1074/jbc.M701973200. Epub 2007 Apr 18.
9
Control of template positioning during de novo initiation of RNA synthesis by the bovine viral diarrhea virus NS5B polymerase.牛病毒性腹泻病毒NS5B聚合酶在RNA合成从头起始过程中对模板定位的控制。
J Biol Chem. 2006 Aug 25;281(34):24991-8. doi: 10.1074/jbc.M600474200. Epub 2006 Jun 29.
10
Therapy of hepatitis C: from empiricism to eradication.丙型肝炎的治疗:从经验主义到根除。
Hepatology. 2006 Feb;43(2 Suppl 1):S207-20. doi: 10.1002/hep.21064.